Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...

Pharmaceutical giants like Lilly and Nordisk are battling for dominance in India’s weight-loss market with price cuts and ...

ChatGPT builds a $1,000 stock portfolio for 2026, highlighting Microsoft, Nvidia, energy and defence stocks positioned for AI growth and market uncertainty.

The FDA is expected to issue a decision on Vanda’s Tradipitant, a motion-sickness treatment aimed at preventing vomiting, on ...

People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated ...

Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration’s ...

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly ...